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Chikungunya virus (CHIKV) is an alphavirus trans-mitted in an urban epidemic cycle by the mosquitoes 
Aedes aegypti and Ae. albopictus. CHIKV outbreaks are 
characterized by rapid spread and infection rates as high as 
75%; 72%–93% of infected persons become symptomatic. 
The disease manifests as acute fever and potentially de-
bilitating polyarthralgia. In a variable proportion of cases, 
polyarthritis and fatigue can persist for 2 years or longer 
(1). During outbreaks, the large percentage of symptomatic 
infections places a considerable strain on resources of local 
health care providers and hospitals. Fortunately, death from 
chikungunya is rare.
CHIKV was first identified in Tanganyika (now Tan-
zania) in 1952 (2). The virus was later found to be widely 
distributed and to cause sporadic, mostly small outbreaks in 
Africa and Asia through the 1960s and 1970s. Little activ-
ity was reported from the mid-1980s until June 2004, when 
an epidemic occurred on Lamu Island, Kenya, then spread 
during 2005 to Comoros, La Reunion, and to other Indian 
Ocean islands, causing ≈500,000 cases (3). This was fol-
lowed in 2006–2009 by an epidemic in India that produced 
>1.5 million cases in 17 of the country’s 28 states and sub-
sequently spread through Southeast Asia to the islands of 
the Pacific Ocean (4). The public health community has 
come to recognize CHIKV as a major emerging, epidemic-
prone pathogen.
The global expansion of CHIKV has been broadened 
by the movement of infected persons to areas with compe-
tent mosquito vectors and a susceptible human population 
(5). CHIKV-infected travelers have been documented in 
>22 countries throughout Asia, Europe, and North America 
(1,6,7); their travel led to outbreaks in northern Italy (8) and 
southern France (9). Until a few months ago, only travel-
related cases had been detected in the Western Hemisphere 
(7,10,11) with no evidence of local transmission.
The first known autochthonous chikungunya cases in 
the Western Hemisphere occurred in October 2013 on the 
island of Saint Martin and were reported in December 2013 
(12). During the next 4 months, >31,000 confirmed and 
probable autochthonous cases were reported from numer-
ous other Caribbean islands (as of April 28, 2014: British 
territories Anguilla and British Virgin Islands; overseas 
departments of France consisting of Dominica, Guade-
loupe, Martinique, Saint Barthélemy, and Saint Martin; 
constituent country of the Netherlands, Sint Maarten; the 
Federation of St. Kitts and Nevis; the Dominican Republic; 
and Saint Vincent and the Grenadines). Infected travelers 
originating from the island countries have carried the virus 
around the region, leading to authochthonous chikungunya 
cases occurring in mid-February 2014 in French Guiana on 
the mainland of South America. Virus spread to other is-
land countries and expansion into mainland areas of South, 
Central, and North America are inevitable.
Three CHIKV genotypes (East-Central-South African 
[ECSA], West African, and Asian) have been described; 
apparently they evolved independently in the different re-
gions (13). The ECSA genotype has primarily been associ-
ated with the current epidemics in the Indian Ocean region, 
and the Asian genotype has been associated with recent 
outbreaks in the Pacific region. A single-base mutation in 
1 strain of the ECSA genotype enhances replication of the 
virus in Ae. albopictus, contributing to the explosive epi-
demic that was observed in the La Reunion outbreak (14). 
Enhanced Ae. albopictus competence is also produced by 
a different substitution in a CHIKV ESCA lineage that has 
been associated with an outbreak in Kerala, India, in 2009 
(15). Sequence analysis demonstrated that an Asian geno-
type of CHIKV caused the current outbreak in the Carib-
bean (12). In this issue of Emerging Infectious Diseases 
(http://wwwnc.cdc.gov/eid/article/20/8/14-0333-article 
htm), Lanciotti and Valadere compare CHIKV strains cir-
culating in the Caribbean to those obtained from human 
serum samples from locally transmitted cases on the Brit-
ish Virgin Islands in January 2014. Their findings indicate 
that the strain circulating in the Caribbean is most closely 
related to strains isolated in China during 2012 and from 
Yap, Federated States of Micronesia, during 2013–14 (16), 
confirming the extent and speed at which CHIKV strains 
move around the globe. 
Such knowledge about the specific virus lineage cir-
culating in the region is essential to understanding the 
potential disease burden that may result. Ae. aegypti and 
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Ae. albopictus are competent vectors of Asian genotype 
CHIKV (17), although there is little evidence supporting a 
substantive role of Ae. albopictus in epidemic transmission 
of the Asian CHIKV genotype. However, the capacity for 
Ae. albopictus to transmit Asian CHIKV provides the po-
tential for introductions from the Caribbean islands, which 
will facilitate local transmission in areas of the continental 
United States and South America where Ae. albopictus is 
common, but Ae. aegypti is absent.
CHIKV has the same urban epidemic transmission 
ecology as dengue virus, with Ae. aegypti and Ae. albopic-
tus serving as vectors (6). Like dengue, epidemic chikungu-
nya is an anthroponosis that does not require a nonhuman 
vertebrate amplifier host. This means that the estimated 3.6 
billion persons in 124 countries at risk for dengue (18) are 
at risk for chikungunya. In the Americas, dengue incidence 
has been increasing (19), indicating that the likelihood of 
CHIKV outbreaks is high in areas in the Americas where 
the population is prone to dengue. There are currently no 
CHIKV vaccines or specific treatments; the only public 
health intervention available is reduction of mosquito-to-
human contact through personal protection measures and 
vector control efforts to reduce mosquito abundance.
The entry of CHIKV into the Americas was anticipat-
ed and prompted health agencies in the region to develop 
preparedness and response plans (1). Now that CHIKV is 
here, health agencies and health care providers in areas of 
the Americas where dengue is endemic, as well as in parts of 
temperate North and South America where Ae. aegypti and 
Ae. albopictus are present, should be aware of the potential 
for CHIKV introduction and establishment, particularly over 
the coming months as the rainy season starts and conditions 
that promote dengue transmission traditionally increase. 
Existing diagnostic and surveillance networks must be en-
hanced, and effective vector control activities must be inten-
sified to address this new public health threat to the region.
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